compounded semaglutide crackdown news november 2025 FDA ESCALATES: 30 telehealth companies hit with warning letters for false claims on GLP-1 drugs. The agency accuses firms of misleading consumers by implying unapproved compounded versions match FDA-approved medications Wegovy and Zepbound prices fall,

According to OBRA, the use of antidiabetic medications should include monitoring (e.g., periodic blood glucose) for effectiveness based on desired goals for that individual and to identify complications of treatment such as hypoglycemia or impaired renal function

Their retatrutide specifically earned an A (Great) rating

However, there are some perceived barriers to insulin therapy intensification

Work with your provider to reduce your dose over several weeks rather than stopping suddenly

If you encounter mild or occasional discomfort, it may subside as your body adapts to the medication

The firm in its response described a cleanroom remodel , but the FDA found the supporting documentation insufficient: no specification documentation for ceiling tiles, no demonstration that materials are suitable for pharmaceutical use, no updated cleanroom certification, and no environmental monitoring data for the remodeled suite